This federal contract award, identified as SPE2DB20D3101 and SPE2DB25FQUS1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,799.06 firm fixed-price contract is for the delivery of 4ML Tetracaine 0.5% Steri-Unit Solution, with a completion date of November 15, 2024.
Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.
The contract award did not have a set-aside designation, indicating open competition. This delivery order is part of Amerisourcebergen's broader portfolio of federal contracts with the DLA and other government agencies, demonstrating their role as a key supplier of essential pharmaceutical and medical commodities to various federal healthcare programs.
Generated 2/13/25, 9:19 AM